Technology | November 30, 2012

TeraRecon Previews Pay-as-You-go Cloud, Laptop Advanced Visualization

TeraRecon iNtuition Advanced Visualization Billing Option

November 30, 2012 — TeraRecon previewed a flexible new pay-as-you-go billing option for its cloud and laptop users of its iNtuition advanced visualization tools at the 39th Annual Veith Symposium in New York Nov. 14 – 16, 2012. The software supports physicians involved in TAVI/TAVR, EVAR and TEVAR.

iNtuition is available both as a laptop-based software solution (no requirement for internet connection), and as an internet-based service, iNtuition Cloud supporting secure upload of image data and real-time interactive use of the full suite of advanced visualization tools, through a web browser.

Traditionally, sophisticated advanced visualization of computed tomography (CT) and magnetic resonance imaging (MR) images has required a costly dedicated computer workstation, but with iNtuition a powerful suite of visualization tools may be run on a laptop computer, or via the Internet using TeraRecon’s secure and HIPAA-compliant iNtuition Cloud service.

For Veith 2012, TeraRecon will preview a new flexible billing option, where iNtuition subscribers will be billed only for the studies processed and/or stored with the TeraRecon software, either locally on a laptop-based installation, or on iNtuition Cloud.

“The traditional commercial model of advanced visualization works well for busy departments with a predictable volume of scans, but it denies affordable access to these valuable tools, by the physicians who process only a few cases a month, and who need to match the expense of 3-D software with the unpredictable economics relating to the procedures actually performed,” said Robert Taylor, Ph.D., TeraRecon president and CEO. “This new billing option will overcome this obstacle by enabling physicians to access the software initially for free, for a limited number of cases, after which they can obtain more credits from TeraRecon, or from other sources such as device companies, or be billed on a monthly basis depending on usage. We are excited about the potential of this new payment model, to greatly improve the accessibility and affordability of advanced processing tools.”

For more information: www.terarecon.com

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart| September 05, 2017
Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Overlay Init